Voyageur Pharmaceuticals (CVE:VM) Trading 14.7% Higher – Still a Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s share price traded up 14.7% during trading on Friday . The stock traded as high as C$0.20 and last traded at C$0.20. 615,500 shares traded hands during mid-day trading, an increase of 49% from the average session volume of 411,916 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Trading Up 14.7 %

The company has a market cap of C$27.20 million, a price-to-earnings ratio of -19.50 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The business’s fifty day simple moving average is C$0.09 and its two-hundred day simple moving average is C$0.07.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.